EU MDR Labeling & IFU Compliance Consulting
Get expert support to align medical device labels and IFUs with EU MDR Article 10(11), Annex I Section 23, UDI obligations, symbol standards, and market language requirements. Elexes helps manufacturers identify gaps, correct nonconformities, and prepare compliant labeling sets that stand up to Notified Body scrutiny and support smoother CE marking progress.
Our EU MDR Labeling & IFU Services
Focused consulting services to review, remediate, and strengthen EU MDR labeling and IFU compliance documentation.
Labeling Review
Detailed assessment of device labels, packaging text, and mandatory statements against EU MDR Article 10(11), Annex I Section 23, and applicable MDCG guidance.
IFU Compliance
Comprehensive review of Instructions for Use to verify required content, readability, intended use alignment, warnings, symbols, and market-specific language obligations.
UDI Alignment
Support for UDI labeling requirements, symbol usage, and consistency across labels, IFUs, and technical documentation to reduce review issues during CE marking.
Translation Readiness
Gap identification for target-market language requirements and multilingual labeling sets, helping manufacturers prepare compliant documentation for European distribution.
GSPR Mapping
Traceability support linking labeling and IFU content to applicable General Safety and Performance Requirements for a clearer, defensible compliance narrative.
Remediation Support
Hands-on updates to noncompliant labels and IFUs, including missing content, formatting issues, and cross-reference corrections before Notified Body review.
Annex I Alignment
Reduce Labeling Risk Before Review
EU MDR labeling and IFU compliance is more than a formatting exercise. Elexes helps manufacturers verify mandatory content, UDI elements, ISO 15223-1 symbol use, language readiness, and consistency with technical documentation. Our consulting is designed to catch gaps early, strengthen regulatory defensibility, and support cleaner Notified Body interactions during CE marking and ongoing market maintenance.
Trusted By Manufacturers
Success Stories
See how manufacturers improve documentation quality and move forward with greater regulatory confidence.
“Professional and easy to work with! They expedited CE Marking for our products and also created clinical evaluations, risk assessments, and provided testing/manufacturing advice.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Created regulatory-compliant supplement fact sheets for multiple products. Their work helped us to sell within domestic & international markets without any problems. They were accurate and the turnaround time was amazing.”
Elizabeth W
“Professional and easy to work with! They expedited CE Marking for our products and also created clinical evaluations, risk assessments, and provided testing/manufacturing advice.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Created regulatory-compliant supplement fact sheets for multiple products. Their work helped us to sell within domestic & international markets without any problems. They were accurate and the turnaround time was amazing.”
Elizabeth W
“Professional and easy to work with! They expedited CE Marking for our products and also created clinical evaluations, risk assessments, and provided testing/manufacturing advice.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Created regulatory-compliant supplement fact sheets for multiple products. Their work helped us to sell within domestic & international markets without any problems. They were accurate and the turnaround time was amazing.”
Elizabeth W
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for precise, practical regulatory support across complex medical device requirements.
Deep Expertise
50+ years of collective experience across EU MDR, FDA, ISO 13485, and global device regulations.
End-to-End Support
From gap review to remediation, we support labeling within the broader CE marking documentation strategy.
Proven Results
250+ successful projects and 200+ product types supported across diverse medical device categories.
Flexible Delivery
Project-based, part-time, or embedded consulting models help teams move faster without adding headcount.
Meet The Elexes Team
Experienced regulatory specialists supporting complex device compliance.
Elexes Medical Consulting Pvt. Ltd. supports medical device manufacturers with practical, high-accountability regulatory and quality consulting across global markets. The company has built its reputation by helping teams prepare stronger submissions, close documentation gaps, and maintain compliance from development through post-market stages. For EU MDR projects, Elexes brings cross-functional expertise spanning technical documentation, risk management, clinical evidence, labeling, and quality systems. That breadth matters when labeling and IFUs must align not only with Annex I Section 23, but also with GSPRs, risk files, and intended use claims. With experience across 200+ product types and a strong record of successful projects, Elexes focuses on clear guidance, defensible documentation, and measurable progress for manufacturers navigating demanding regulatory pathways.
200+ Product TypesExperience spanning diverse medical device categories and technologies.90% Audits ClearedStrong inspection and audit readiness support for regulated organizations.250+ Successful ProjectsDelivered across regulatory, quality, and submission support engagements.
Frequently Asked Questions
What are the labeling requirements for medical devices?
Medical device labeling requirements depend on the market, device type, and risk class, but generally include the device name, manufacturer details, intended purpose, warnings, storage conditions, traceability information, and any mandatory symbols or identifiers. Under EU MDR, labeling must also align with Annex I Section 23, include applicable UDI elements, and remain consistent with the technical documentation and IFU.
Are IFUs legally required?
Yes, IFUs are legally required for many medical devices when safe use cannot be ensured without them. Under EU MDR, the need for an IFU depends on the device and whether users can operate it safely based on labeling alone. When required, the IFU must contain specific mandatory content, appropriate warnings, and language versions suitable for each intended European market.
What does EU MDR require for labeling and IFUs?
EU MDR requires labeling and IFUs to meet Article 10(11) and Annex I Section 23 requirements. That includes mandatory device and manufacturer information, safety information, intended purpose, residual risk communication, applicable symbols, UDI details, and language compliance for each target market. The content must also align with the device’s technical documentation, risk management file, and clinical claims.
Do all medical devices need UDI on the label?
Most devices placed on the EU market under EU MDR are subject to UDI requirements, though implementation details vary by device class and regulatory timelines. The label must include the appropriate UDI carrier and related information where required. A compliance review helps confirm whether your device falls within the applicable scope and whether the label presentation meets current EU MDR expectations.
Can we use the same label and IFU for the EU, FDA, and Australia?
Sometimes partially, but not without careful review. EU MDR, FDA, and TGA labeling frameworks overlap in some areas yet differ in mandatory statements, symbol expectations, language obligations, and market-specific formatting rules. Reusing global labeling without jurisdiction-specific assessment often creates compliance gaps. A structured review helps preserve consistency while adapting content to each market’s legal requirements.
How do you review an IFU for EU MDR compliance?
An EU MDR IFU review typically checks mandatory content against Annex I Section 23, verifies intended use consistency, evaluates warnings and precautions, confirms symbol usage, and assesses alignment with risk management, clinical evidence, and technical documentation. Reviewers also identify translation gaps, missing statements, and unsupported claims so the final IFU is clearer, more defensible, and better prepared for Notified Body scrutiny.
What are the most common labeling and IFU compliance gaps?
Common gaps include missing mandatory content, inconsistent intended use statements, unsupported marketing claims, incomplete warnings, incorrect or unexplained symbols, absent UDI elements, and poor alignment between labels, IFUs, and technical documentation. Translation readiness is another frequent issue. These problems can trigger Notified Body questions, delay CE marking timelines, or create post-market compliance exposure if not corrected early.
When should labeling and IFU compliance be reviewed?
Labeling and IFU compliance should be reviewed before Notified Body submission, before market expansion into new EU countries, after significant design or intended use changes, and whenever regulatory requirements are updated. Early review is especially valuable because labeling issues often affect GSPR mapping, risk communication, and technical documentation consistency. Catching gaps before submission reduces rework and helps protect timelines.
Still Have Compliance Questions?
Talk with our regulatory consultants about your labeling and IFU requirements.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise.
MDSAP
Multi-market audit readiness support.
IEC 62304
Software lifecycle compliance knowledge.
